IMPROVING DISTRIBUTION OF COVID-19 VACCINES; Congressional Record Vol. 167, No. 22
(House of Representatives - February 05, 2021)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page H393]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




              IMPROVING DISTRIBUTION OF COVID-19 VACCINES

  (Ms. KUSTER asked and was given permission to address the House for 1 
minute and to revise and extend her remarks.)
  Ms. KUSTER. Mr. Speaker, across the United States, Americans are 
finally seeing the administration of COVID-19 vaccines improve after a 
slow rollout.
  The development of two highly effective vaccines in under 1 year is 
an unprecedented scientific accomplishment, but this effort is only 
truly recognized when we can get vaccine into the arm of every American 
who wants it.
  That is why the first piece of legislation I introduced this year, 
the Coronavirus Vaccine and Therapeutic Development Act, would 
dramatically boost Federal investment in manufacturing and distribution 
of the COVID-19 vaccine.
  There is no greater public health priority than getting this vaccine 
into the arms of every American, and I am committed to working with my 
colleagues on both sides of the aisle to ensure the equitable 
distribution of the vaccine.
  To improve the facilitation of vaccine distribution, I have also 
introduced bipartisan legislation with my colleague, Dr. Larry Bucshon, 
that would improve and expand information-sharing between State and 
Federal governments to ensure that vaccines are being administered 
effectively and efficiently.
  I urge my colleagues to join both of these bills so that we can save 
lives and get our economy back on track.

                          ____________________